INM
InMed Pharmaceuticals Inc.Company Information
- Company Name
- InMed Pharmaceuticals Inc.
- CIK
- CIK0001728328
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INM: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- INM
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-16
- Last sale
- 2024-07-31
- Shares purchased (TTM)
- 512,019
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,697,636
- Shares outstanding
- 4,163,598
- Ownership
- 64.79%
Earnings Market Reaction
- Filing date
- 2026-09-09
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | - | 5 | 7 | 9 | 11 | 5 | 3 | 6 | 7 | 10 | 7 | ||||||
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | |||||||||||||||||
| Assets Current | 3 | 7 | 9 | 11 | 13 | 6 | 5 | 7 | 9 | 12 | 8 | ||||||
| Inventory Net | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | 1 | - | - | - | - | - | - | - | - | - | ||||||
Assets Noncurrent | |||||||||||||||||
| Property Plant And Equipment Net | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | - | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 3 | 9 | 11 | 13 | 16 | 9 | 9 | 10 | 12 | 15 | 11 | ||||||
| Accounts Payable And Accrued Liabilities Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | ||||||
Liabilities Current | |||||||||||||||||
| Liabilities Current | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | ||||||
| Operating Lease Liability Current | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Rent Credit Current | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | 1 | - | - | - | - | - | - | - | - | - | ||||||
Liabilities Noncurrent | |||||||||||||||||
| Operating Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | - | ||||||
| Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 1 | ||||||
| Common Stock Value | 94 | 93 | 92 | 92 | 91 | 87 | 85 | 84 | 83 | 80 | 78 | ||||||
| Additional Paid In Capital Common Stock | 37 | 38 | 38 | 39 | 39 | 35 | 35 | 35 | 35 | 38 | 36 | ||||||
Stockholders Equity | |||||||||||||||||
| Stockholders Equity | 1 | 7 | 10 | 12 | 13 | 7 | 6 | 8 | 9 | 13 | -10 | ||||||
| Retained Earnings Accumulated Deficit | -130 | -124 | -121 | -119 | -117 | -115 | -113 | -111 | -109 | -105 | -104 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 3 | 9 | 11 | 13 | 16 | 9 | 9 | 10 | 12 | 15 | 11 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Common Stock Shares Issued | 5 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 5 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInMed Pharmaceuticals Inc. (INM) — SEC Financial Statements & Analysis
InMed Pharmaceuticals Inc. (INM) is a pharmaceutical preparations company, incorporated in A1. InMed Pharmaceuticals Inc. trades on Nasdaq as: INM. InMed Pharmaceuticals Inc. (INM)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-09. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), InMed Pharmaceuticals Inc. carries a market cap of $6.45M, a P/E ratio of -0.51x, a P/B ratio of 6.00x, a P/S ratio of 3.33x, an enterprise value of $4.26M, and an EV/EBITDA multiple of -0.34x. On profitability, it posts a gross margin of 29.73%, an operating margin of -586.15%, a net margin of -647.36%, a Return on Equity (ROE) of -173.14%, a Return on Assets (ROA) of -134.99%, and a Return on Invested Capital (ROIC) of -404.05%. Per share, it reports EPS of $-3.02, diluted EPS of $-3.02, free cash flow per share of $-2.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -60.74% year-over-year, net income growth of 53.89% year-over-year, and EPS growth of -63.93% year-over-year. On the balance sheet, it maintains a current ratio of 1.37x, a quick ratio of 1.25x, working capital of $721.65K, a debt-to-equity ratio of 1.82x, a debt ratio of 0.65, an interest coverage ratio of -4233.23x, free cash flow of $-8.64M (TTM), and net debt of $-2.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $6.45M
- P/E TTM
- -0.51x
- EPS TTM
- $-3.02
- P/B TTM
- 6.00x
- ROE TTM
- -173.14%
- ROA TTM
- -134.99%
- Debt To Equity
- 1.82x
- Free Cash Flow TTM
- $-8.64M
- Net Revenue TTM Growth 1Y
- -60.74%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is InMed Pharmaceuticals Inc. in?
InMed Pharmaceuticals Inc. (INM) operates in the Pharmaceutical Preparations industry.
What exchange does INM trade on?
InMed Pharmaceuticals Inc. (INM) trades on the Nasdaq.
Where is InMed Pharmaceuticals Inc. incorporated?
InMed Pharmaceuticals Inc. is incorporated in British Columbia, Canada.
When was InMed Pharmaceuticals Inc. (INM)'s most recent SEC filing?
InMed Pharmaceuticals Inc. (INM)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-09.
What is INM's market cap?
InMed Pharmaceuticals Inc. (INM) has a market capitalization of $6.45M as of 2026-06-30.
What is INM's EPS (earnings per share)?
InMed Pharmaceuticals Inc. (INM)'s trailing twelve month EPS is $-3.02 as of 2026-06-30.
What is INM's ROE (return on equity)?
InMed Pharmaceuticals Inc. (INM)'s trailing twelve month Return on Equity (ROE) is -173.14% as of 2026-06-30.
What is INM's ROA (return on assets)?
InMed Pharmaceuticals Inc. (INM)'s trailing twelve month Return on Assets (ROA) is -134.99% as of 2026-06-30.
What is INM's ROIC (return on invested capital)?
InMed Pharmaceuticals Inc. (INM)'s trailing twelve month Return on Invested Capital (ROIC) is -404.05% as of 2026-03-31.
What is INM's EV/EBITDA?
InMed Pharmaceuticals Inc. (INM)'s trailing twelve month EV/EBITDA is -0.34x as of 2026-06-30.